$5.670
-0.146 (-2.58%)終値時点
PYPD の収益性とマージン
Evaluating the bottom line, PolyPid Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -243.59%, provide a clear picture of how effectively PYPD converts its operational activities into shareholder value.
PYPD の同業比較
In the context of the broader market, PYPD competes directly with industry leaders such as NERV and OKUR. With a market capitalization of $115.16M, it holds a leading position in the sector. When comparing efficiency, PYPD's gross margin of N/A stands against NERV's N/A and OKUR's N/A. Such benchmarking helps identify whether PolyPid Ltd is trading at a premium or discount relative to its financial performance.
PolyPid Ltd の財務パフォーマンス
PolyPid has reported a net loss reduction from $10 million to $7.8 million year-over-year, indicating improved operational efficiency. The company's cash position is also solid, with projections suggesting cash flow will extend into 2028 due to milestone payments.
Financials
関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。